NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 127 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,990,000 | +2.0% | 1,298,908 | 0.0% | 44.41% | -1.9% |
| Q2 2022 | $16,652,000 | -15.9% | 1,298,908 | 0.0% | 45.25% | +2.9% |
| Q1 2022 | $19,808,000 | -13.9% | 1,298,908 | 0.0% | 43.96% | +5.2% |
| Q4 2021 | $23,004,000 | -15.7% | 1,298,908 | 0.0% | 41.78% | +3.3% |
| Q3 2021 | $27,303,000 | +6.6% | 1,298,908 | 0.0% | 40.46% | +94.9% |
| Q2 2021 | $25,614,000 | -32.2% | 1,298,908 | 0.0% | 20.76% | -28.2% |
| Q1 2021 | $37,759,000 | -4.1% | 1,298,908 | 0.0% | 28.92% | +0.8% |
| Q4 2020 | $39,357,000 | – | 1,298,908 | – | 28.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $19,406,306 | 12.88% |
| StepStone Group LP | 1,573,357 | $1,683,492 | 0.38% |
| EcoR1 Capital, LLC | 6,435,518 | $6,886,004 | 0.23% |
| Euclidean Capital LLC | 1,984,336 | $2,123,240 | 0.23% |
| Boxer Capital, LLC | 500,000 | $535,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 213,676 | $229 | 0.02% |
| Jasper Ridge Partners, L.P. | 303,492 | $324,736 | 0.02% |
| Carson Advisory Inc. | 15,850 | $16,960 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 51,176 | $54,758 | 0.01% |
| Parkwood LLC | 68,314 | $73 | 0.01% |